FDA Approvals in Oncology: January-March 2024
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
Category: FDA Approvals
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
In the final quarter of 2023, the FDA issued 17 approvals specifically for the treatment of tumors.
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...